ࡱ> n.aƑ*E2PNG  IHDR_^r_sRGB pHYs.> IDATx^O5 #xf ـî!` @ VmNrnI77Pt 9Y>f,A4 v!W55=ӣQij}_ս_r/Go)A-:e﮶>ol]y}t+{Hj?|t~?֙ӿ=zTkmWfhex[zFOmZ/H+o "+E4ǾGg0'sšj^otD \ Vngf?n?|(.:>ܬ$NΫ":yhIkXfs:2UGs3ޫ⋔~[CgR2oVv%({6fq# ܲzHZ2 1[uQ@OہV^j &/ o?x`}U S7̐JGTIœqɚm |t|aʘ+K{2e &vO͓w^fXq3R}00ٸpxJ_F t-.vI)ɄOrK@)Pƽ՛_Zp8, NNIde]^D:X|5&fq-a@GO tFCU]b6+:o]y~t4ϘPkLS1ՖMК"Rs3OCtdԕ)E[vHFK7Dy dgQ!lKw; GҀx:Ί|FG2̣\Y$|=t&er[:.JBFvJ'֥25Qaʭ BZ=Lz*:ʥA}T,\VKyR)$tndeDվĦ^a$tXY N+Xe"V 1а!gWb A< dL[f\OYZr0*\S mzJ3e:%glU:I^Cc4g|]&u_:Щ(q4hL:Mk9%d>q$6&ʶ$*H»WR|H" F#qt,Zv>ݥP}գAΉ St4 hZA'hZj`8$ŋAVW nȸZT@GD $+%JZД.e)_}{&ЉB`H[X8XWI"h8߬pW׬5HSZ)<\ڑt9=_>5Rwt\B?ru9=~''}wܣ;܇ 󳟯؝ ͋Ýkgxv|o~ ORf'Ĭ[b>{,aD|GyQڜyGZP# m;f,?U I{iKڌ0R;/yYiŒ?(1+ZF܊ [7RVF &n"/M;un:CYL@ B:(3^HgKvB|ndze>ShM[ Ll Ҭ7>4S b FUIQ-=9b7;bUdgњFǙ˧|wBA=檦ugLT7K-Tp"mVZ0[*,.R6U&qPs)hr2YJ3Cߘ@AcHJϯޓUج|V SbUpp_}T$@ (?^rL!eiXp;A.3 ~v9F˨H/y: T?^!^ϩ|ȯ}ae/}%;ѻ>4{-t3tׇ>ca"LφSآv pe-ޅ^x;=BAXQWeO}\HI =!dc_ C1( e=U=5= ͠%{t=/ ~ [~`캟l4iWe%.Uv~bgv;w)NvG?a)8k v_?Un-^?]/mm;?6m{nV0nVn(n-| ,MM8֍ Y]鳹:CGݵ6 Z@3h >a\-Q*By-|&WX v~>r4.;{S/OҲ>Kɾ.x.71}T."a$b0^\hS]Ga[΂twi5.w>nwnu`q[fbg/l{s737FS7~'Ǯ;tG5FP8|մTvϕ2PCBv凼r 2C&mnvå.]vKeKi\r;Q8؟.slK`;\|Fֺ8 Vض XŴy.r \4c`j#abCalh=` o]8kM]Xk]5 m ee i ʊ00b<7{Ysl1Kh8wzl֥&KcɰYblZ,~u9-m!vC|p+h߭}B {xj:V3W=lp5-nj!wMZ]r;1k%wPjuKkZmպnwmVh3L-nqstjg7I ͍nt#}Pi?7P~룃\OPEN:ܵב?\+ZTǡhǣh'z:ɮNuu:v3]WF纒:UUŮ.A.E.wu%v v-vK]Z&B%.tnCrhE. QEPp]lSuR*RέRnw$ RЭ-ܐ-2---nu $/1hTy 5LC)XrGcMMk\& Pi"9&Ljr9)/M%4 S6.5l|N -*ҲBr Lk@m)4gL+ƶvܖr4gec2S?e]2[f#a̕2O"ϯ@fBf[Je,0Qd 2PVH?#Й::i̭eT6IcVk [lڬ^CK5!UeTbGd=RZII/rP ! a-G$rB2)I'g$rQeI(W%ܐ8rKx!$<(X"c\cpZb_䣄J )! _ DHC ō~XH2 ˭4^in;d%Bsy4'2 EDdi"<Yh RhK$6 h iA4QIf o!C4 0^Ǘ"-GV"2Ue+ѸS>m(cBN"yO:HxIM6K<2brIh%mԶC^e H  ԰;ddӧ^aJ;(tLZHh -:bDS,N:K-.ԺrK+-6*eS)DwZA` ^gbQ˭p/%ˡWe[pcx-|/3riChGù|ר klWTbĮ&Gyr5Q$\U͊BɁRɅbkALRK֨Z&vNZ]gXXWu]7XwXwmzzh+T[]/TW/V/V/TV/UOUOUOUOxnLi5f<_:Kafu}la?aO{QNss<\p|F'WO^'LӠO4s&+_! riMY!-y5)^ o~ۤ!}.@@C2a 'd?-#YßQe*c oxW&2?I_kGtCfxՙ, lA(:|lBB]BRQԥ>/e(徬u 5u uo -uotuttua>,M~9 vfa8\kpK|}O%~f&B !m!5̶gܶPRP*Z_ j_A3[[*:Jz r?ĖԏqOϴE~-a-l_iZ`sflf=66i(Mgm?o%XFGj# _6?W;{·tm%>t͠)4PLJp5:TwWG ⟈zpw( W^'7Ư`Ԑ X) N ,SfX =N?3:cd32m lnn,t e1t+JVoa?uϭiY;_%mXS/7W wU2T_qsEx`|̛sNNκX?3~2/-L~S?9HypĜ/Lysx7{.OL{EnѰ_T{FƮo${Gx!<{ r_a0_1 { W  X45 55o M4"&5/QHQ=J,gd>"i2o>4>/7MKbI%̙,l̚ l̛ɟdG$;9'Y:7:-N)K!.{ًKRP~C5e|sk󭙧-c߉u^W=GoӇ}c@;}fC803s|pќw a c"v}&c)k*vasv}ga{6vrsy4Ͻ-p υBw7D-JW~ޚ3QC2.zwЬԖlfd55'o}i^_GZ¾8, e_j<pﰇ[ |G9!u3њ~l [lЪ u2{DMľ+%Z/nsT-'bquxJtAoĂbn~^?4 gDPTb$rNT$qhK MF]xc&G%  ᩃށx@2 z0= /GcDD"c Q2I!%QKaѵ([OmDN^p< ٘nL6"z P z͜ԏXu,Ї>UFV"5l|+A +cYIJp(V V1׹}t3YQęx>-  a aa ~A (؟xoߝ/əN{~#~5M/c_BElO}zֺw7:f:&Wt{#`{C8x=3 Smm4sO]h}c1{L=~D<>E 䇼q@sBv OԐZrKOR'L9o"lfa.pޅ.Ep-j!]43~گ>{x %<Cf,ݱ(v nZ$jsNYh;n!y;df'9/Oꏺfd'u M:8>VE΍q )98=䀂JZkA#k>BYsÚDk3ηƺ:kzzq笖^z۪Ss ԷVE?[%r~r}y|YJk4W^^(J.\!rurt>7r@v-jeYZۥoҒSksR[VRo x: 8:~Uf1. :vw!ykGl4wߤ"'MTͽs{!EsJNX2G=$tw%-Q- nJHw]~UhW]vQnh夝CvVvdevR geZih:$Ią~Ay ð Rd"tG I'%zZEϊ9,\rQne~]3rUu9 7eܒMZR/̐G2'S!e~JzV; |E7i(?ZbZ]JH,NJ-#DR]KJ A%ϥ̓22ofIJvm(9WH~ ^RDI:BJX)ΐr:ORn*STޖ:Xk6_F[hbmifO[h1mbd_]׶:&j; Ka=1 YA[qAb#VL,W{ qK|- NB% Mf3I-hk!%vIJ]$~4P<\2(,=N2a,: kϒlX..\raܺAV, fA|V,^⛏RBs_ 2Zj-ѵ5ʚAhvU5@1TضĮ50W::IaӽpU =dÈ@JȐ!!&VdNЋ;:99AYUBcQȴɴ'Ӗ%Ӗ!ӖFmBeVe]LC hd2ktWl[*j jUs,dT،T d޴4TTTTTZ%j'% 'ц.8!=="qqɤqɨ1/H:܅G9/A"^d2w4$x>Y;!sedd̟5v.ԦTFT p54ա4\M9_+-i1יsw/v]>L 6հB㸵m[AE۫aA 厩svvy޳z .X;8*8Zolų6Xr[mimeEZ.imVFYnlU~VzZj 56ւ_m1o]j*[+m4 8k-3gfY:VKm"KbK,g+7vZ v6i6iXfam'zf7'ڋo.FkbC虿-|G<ѣsޅ[x '2\=g$SvA8x}Y˜9,eĖmN0l6DM'OWGF l K3/_ku6 ttD8thHQ>O$&{XIb i˯-,6l2iK5,VdZi%,"Yk6 kZ))$Jl{)(Rd$ݑvC-]/Gs#4]r -tr<|X])ul#GoFr*"*s3tL2^G(&>^QK[B $M -5TT&RVkSjRjPQ/R;PG*SS*Qc*Ro*P{SRH\|+j?oC}pBA#+`USjw-_%'1VZcZڢiK鄾.Ϥ'< AQhqhrGf栟 YZ!d j#j+*k\}hChchSrpON)V?:.㨧cDDD8hH І9!I= 64Խ^i{=Xjd `*h-l]Cp.Mx- !ĆA 픲PvI Mm7ZytG`+#`0|Xjdl?ey7>'W7hOnr%;#Y1y]"uIR˒] *5NOݐ|;R'e!*KTr^X'R>{&u9{4i^K3r省(gJWNmv! J1~Ƅ~)dLtFHTTpڍ~ sutBPiUVB) Y>I-Q{JU*^KKgE!Yrsd|9gZΜ qD!=Vll+"`_YPncݒ7v;]ήsw׸ë w{;,{w~(kǖя-YdSa<}0l?Z@#BE(E2A|%ćXAH o9S?0{'2 e;S8Kƾ-ԓȸQPPcllaM̻P[z+Yw9)*bH7'mtfI+)m44mSMPA)(E \ =ϥB< 1 DBA3SP+N;-c~2LΟ y~(>ROF  ~C:<[93_@"A#~@/"~%~⨹b,WT~"t#8SAKI !%2A9 P CgPAUC5aťj@)JIchjeDzg9ioQJzYecUŪ2eUCTk,k;S]@XCfd5FU49TY3TF Yd-QmPeuDt-][/Th_gP) E62NND9}.+5[庭 a;B8Ę#p*qtet tuX:OL%3|%&Oljc䓣_CAbG%w[xu%Nu6Y < B\q/I^91w֩ȚWV]M_ Zzn-wxlu)'LƋ@ C pA>3zM>*F[hkm\@ßmr M mXA]+{tMfz >-?}???~` !&KTI?Fpe= A=Jt4S{WϽ"LXH{%B`A⟧/kPө.j/:ZJm@y UPFD[+w:X[= UcݭW{Za(Q0qcavyW453rgcWuG1e] NyTDMW쪨@wc\j2wh۩5t/b>ͼyAwTC{Y耮 ]!zE%z :J-:MtJ' z\G_лEsOz.GMe'|Wgmff=Ȼ( 8gzE,nm <^;~OgOS[,6/dzdۊv`]Xo~MDLbir;Ohh:i \&nj2nV{f##g#;g#Kg#cgϼOƫe&g&g"g0Tpʐ֢Xfo)-$%:Z Oy5說 dL<Q!sXDS8j`XG)jY(ԙN닖֔gJ 'jωcrCb>1xqxxEcvz<{n901'1ELnnX;1V2bq ,tls: ؉<3wNb)ڑ1l&9~6k#,`E}-ԮPZUjX%jXyKEޙNM&&k +AF:Ds o dl7 k3Mx14`ztuY璟?K.Y7QVI::k2 5PA(!eˍDmBmAmGqMnuZ(G[R]ߨ_wY_^pWOG}<wyN5;3I10^gP_u#?[m!m9նWS8{>OJ ‹},'+:,uB(mePie J!ڬUEUVڮUr(mͬbh"(4[Jlt7ѲZoV߉ADv5XANGmcq~6L!ҦӉDLl6Q6(cDkmF@<ѵDzn5݌L$m[5[9[DV;> c9LTm&m"m̳93RX:akxJ}Mx2*|1_wϷ>:wF [v: :l̓k<=wT~ֈ(nB6#j[mmDjG":DlO"UQ; ;;>2 3G@֙jF$ZD| ":9mհHBrة *M/ K`bd[o.7E^97//Y0;1+; ;=H4N͝£SID gdܜɂdcr1yy03Ք NJ5]ūp 'L%a7Xy{%bÇʻX2ǣRUC9p;f>xT)Xi<*r"/[N~X'_l&oo껰^u(F_0>a9bhztC#69^>  o{W;ޑS?u_xC ZZZZ^׆|ؖؖ؎<ٞhv鿟䗖X?T.bRZCiIu$ԆXiSh.$֒TBI$SRhI%ZI4xZx:y:tzz*t,h,6H6Cr+oȥSGK^zz]mɯ>RP')@0ZT#B4 XZLiqM )LZRC^-4#{e5jk9mMZ YA{3b QZITF `Vհb DY4Qh@i>7tCC o z-3CgU*ZBELިLdU"*QCOWP/*w+GYWh)K+C!?&_"$$*J%t-NDPE霋 Su{˫sM΅sjDώggj|όgҔ.q4=dr5K9\Zh^Z TZȥԢP̥В.vɴK塒KKաKu\micWߴ]lmbiS_\Th?Y@Iu( <;$o~`~՟5~OX_ىgm8GKӜs5| 8o]T9q+9sr\;wOpyG^tpVW{n_N][;ؽ/=>JhhW)=g=?yO:\ƿkcxC6ѩtzK`lN6 nNІ:tu5 <>Q3@jH "BC6ѷ1XAثѭ5"2mHl7$  ZPOBKKΨ;T PZkjjAy::9&'32"D#D0䘐M*ʓK)O,9ށRZ)gzJqy5@JQ뤈˥P |C ȫSȱɵa y7_ACɃ` ?&_ ow!w %&7'7%7zԀ:PP8 (u)%)P{EԨbԬKg^C?y.URo(xhD(J.3 9Fp2 &?%,r)j)j)G'P[[=U Iֶ{ޛu:+K 3Q!r~:=(.ryJg31֣x֢5MDDBBB'B $'2v|=]Q&]оѾ ҚX: 9w[s.,9*+{*ʱDz 4T)TUIU :⨭bX%VEVeVV[䧻΋}rr' φjogС"-6OS"Sa%C&E&qg Pxz4<hxΝEu T+キK@@D}5ݺ`ݎ ]׎CvC{p(AxPnb8@ΰ1x$na 0n!H/ V6jy\M?zY{Dg Ax!JEUU+vj]<'9__;^_}v|0w/ҟjTP{t5NGUsWCWC"H!2C6s /BPAI(Q'Q/S;k 4u5&0ݢQ0=O)΀0E Vq׭=w?#w4sO"\&7{s}Osx^[>7F!ЈԨҘ 7MkJCejټY,7V VoxcKl)˜X|W|!{o/{=@= 7]p1;'pHNa'l 6:X`,%̳9L0}Mbdf#d 6H6@heGV[/Yi=eu%UYgoduY^[[jmd RZsed5aH[Ch Փ>VWzXjՔVCXuieդJ* ԳB'*5Zb奢rPJ +#P Zi!'dR2BzH 9$DBǂ@$X+ dm>|*EG&ѡoѣoХѧ/ѩ/4F6׊1mێglG@W`Ggݘ;k`;Gz礐1i lv GQ(%P;*TPBhMZBh<3swEzV_!e`o18'6o.36D0|g$>4ZwlɲΦk3ٲ e ݊oŗzx}}=xgpF6yW;wx/5ϾA4(?jh40O#"r GȧY觟q!C ;mF E5@ ~O?[2h 60: LDD/long-acting DHP-CCB/ARB (avoid -blocker or alpha-blocker as initial Rx) -blocker -CHF Z+ZZ+ZZOZZ(M 0:U S L$BTop 10 Failures to Implement Evidence Based Advances in CV DiseaseCC$ASA/Plavix-CAD/ACS UF/LMW Heparin ACS Thrombolytic/PCI-STEMI -blocker post-MI ACE-i/ARB CHF/LV dysfunction Post MI Vascular disease/DM Anticoagulation in atrial fibrillation jZ/(=.' Lipid Lowering 2 - CAD, CVD, PVD, DM 1 - Risk Factors HTN (hypertension): LDD/-blocker/ACE-i/ ARB/long-acting CCB Isolated Systolic HTN > 60: LDD/long-acting DHP-CCB/ARB (avoid -blocker or alpha-blocker as initial Rx) -blocker -CHF Z+ZZ+ZZOZZ(M 0:U S M%DPotential Cumulative Impact of 1 Prevention Strategies.E-$"$$(8Potential Cumulative Impact of 2 Prevention Treatments.9!$"$$O'CVD 2 Prevention Cocktail $   /b c d f    0` ` ̙33` 333MMM` ff3333f` f` f` 3>?" dd@,|?" dd@   " @ ` n?" dd@   @@``PR    @ ` ` p>>L0  l(     Nh  ))?"0    T Click to edit Master title style! !$  0|k  "   RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S  0q  "``   ,  0Ht  "`    D Continuing Medical Implementation & ...bridging the care gap \g&"&*      0}  "`    D*  T32 @1?"`  T  @1?"x   <A ??"`X B  s *޽h ? ̙33 CMI Template 0 h (  h h NQy˼y˼ .  t p*  a00aa h N[y˼y˼ 3 .  r*  a00aad h c $ ?  4 h Nxey˼y˼ 9 f  RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S  h Tky˼y˼ r   p*  a00aa h T0|y˼y˼ r3   r*  a00aaH h 0ηo~ ? ̙3380___PPT10.G 0((    Nty˼y˼ .   \* a00aa  NP7. y˼y˼ 2 .  ^* a00aa  T7. y˼y˼ q   \* a00aa  T4 y˼y˼ q2  t ^* a00aaH  0ηo~ ? 3380___PPT10.)Ɂo   0L0 ~v(  ~  s *  0      c $  P p<$ 0     c $  Pp p<$  0   H  0޽h ? y___PPT10Y+D=' D= @B +o   0L0 ~v(  ~  s *  0      c $8  P p<$ 0     c $  Pp p<$  0   H  0޽h ? y___PPT10Y+D=' D= @B +   0L0   { (  ~  s *( t 0   t    # #"" t  B$t?@ x  I5/6 @`  B,t?x @  [Cumulative Prevention @`  B5t?@ x  I1/6 @`  B 7t? @ x  [LDL reduction 1mmol/L @`  BFt?@ h  I1/2 @`   BLOt?h@  ZBP reduction 20mm Hg @`   BXt?@ h I2/3 @`   B`t?@ h WSmoking Cessation @`ZB   s *1 ?ZB   s *1 ?hhZB  s *1 ?  ZB  s *1 ?x x ZB  s *1 ?`B  01 ?hZB  s *1 ?@ @ `B  01 ?h`B  01 ?h `B  01 ?h `B  01 ? x `B  01 ? x `B  01 ?x `B  01 ?x H  0޽h ? ̙33___PPT10i.>{+D=' D= @B +   0L0 @,,44(  4~ 4 s *04  00P      4# #"."yyyzyyy 4 <`#  ?"`@  P1.7% @` 4 <P  ?"`@ ~   P2.3% @` 4 <X ?"`@  ~  P3.0% @` 4 <X ?"`@   P4.5% @` 4 <0 ?"`@  N6% @`  4 <4 ?"`@  N8% @`  4 6?"`@  T Event rate   @`  4 <, ?"`  P3.4% @`  4 < ?"`~   P4.6% @`  4 <H ?"` ~  P6.0% @` 4 << ?"`  P9.0% @` 4 <h< ?"` O12% @` 4 << ?"` O16% @` 4 6H<?"`  T Event rate   @` 4 <'< ?"`~ @  O25% @` 4 <+< ?"`~   XACE-inhibitors @` 4 <:< ?"` @  O25% @` 4 <@=< ?"`  W Cardiac Rehab @` 4 <|E<? @ ~  O30% @` 4 <T<? ~  XLipid lowering @` 4 <W<?@   O25% @` 4 <f<?  |b -Blockers4   @` 4 <k<?@  O25% @` 4 <g<? MASA @` 4 <}<?@  D @` 4 <<? NNone @` 4 6<? @  MRRR @` 4 6\<?  > @``B  4 01 ?  `B !4 01 ? `B "4 01 ? ZB #4 s *1 ?ZB $4 s *1 ?ZB %4 s *1 ?ZB &4 s *1 ?  ZB '4 s *1 ?~ ~ ZB (4 s *1 ?  `B )4 01 ?6 *4 0d< fAdapted from Yusuf, S. Two decades of progress in preventing vascular disease. Lancet 2002; 360: 2-3. Tg(2_&&& ` +4 s *"`0  ,4 6X<"`P PCUMULATIVE BENEFITS ARE LIKELY TO BE IN EXCESS OF 78% RRR, WHICH IS SUBSTANTIAL$Q0 QH 4 0޽h ? 33y___PPT10Y+D=' D= @B +;   0L0 JB(  ~  s *lkt 0  t    `otv @  p `  t CAD, CVA,TIA, PVD, AAA, Type 2 DM Same Disease/Same Rx: ASA Lipid Targets TC < 4.5 LDL < 2.0 (1.8) HDL > 1.2;TC/HDL < 4 TG < 1.7 ACE inhibitor HOPE Trial EUROPA Trial -blocker for post- MI, HPT or CAD9ZZ8ZZZ#Z"  #  #$$  BA j0232659  tB  s *޽h ? y___PPT10Y+D=' D= @B +# 0 4(  d  c $h     s *h9 f    H  0ηo~ ? ̙33$ 0 4(  d  c $h     s *!h9 f    H  0ηo~ ? ̙33$% 0 4(  d  c $h     s *$h9 f    H  0ηo~ ? ̙3380___PPT10.P' 0 0(  H  0ηo~ ? ̙33( 0 P84(  8d 8 c $h   < 8 s *<h9 f  <  H 8 0ηo~ ? ̙33 xF9 BB0~#$@'&_1b/t "S%5'흮vFJo{jzK+iG3yH[yە?3>ɮU7e7íY~pH>Z_Cr#M$GILZ[H^*Fr;I yɝ$o$9N&$w-$w$$yɻIC^$$ɇI>Br^|$ $<e mvYy/kC)`7oOX^}(Y e.9/LCl]WPȁJ:-!2*ca;hOj>)鋆DF'2tcB"E6J=Jl8:S9^WrG|0cVdmMxuhI9I-^>bKm)BӦyVFŔB%4icKH&7_MڢtF]Qu^Ks)miҷuŒPQqC]@ Y/jÙTiڼ)>hH2=3bn j-a**-]o[m巺ib6}Th4:R(%>/lpvFiűSP+A-눿&_iDlM&Xx4em`C˱.LJT CBH<ʹlJ#i jO{Ϋ ^-e ˃G!T91)bٶ /'9J3$bZ##=8HF3TQmʚ Zz[>l|04etz쿊-M_hҾ|ɭ4:IKͷQͭH[&"}fX6p4Rke&> GkqB!ibU eOڨlhˋsPB$h}|А 9e"ADcy0rhR5el%)ѵpтh- I ֺI>6H@ZDakrk:|ZWKv9F lіFL">>~kz(%0i)|x&2 q')ק6S.ߧLCddGF EXJ-L ʬ-tI&zi> `(>oNO>9Our櫀0>C\!|UҾ&ŇA*'<ᔧ'ݽ}IasLOG |~_L |66BOԻ*<}dz#\V>3xgf,>y0DT|Ē<{ߣA/7Ƨtj|NG>Kml>|QD]>yPՌV>:Q ّO:&>yw8D5MsO ϔGtc/iGϗU)jSw3؃'ݹӡ >6&C>55 >99R|&չ'_^M!N!a)rb^3lvK-/H\e>(@(_yQɶd|O}sd[|ht>g8#.v+? +aNyR{NyhL_%F!G ħuC蹇= sI>ѵ yf bDS67?`Ƭ~ۚX_ђ~|R 5mA c;JEiC{h"ˆuTt=%bZŅ-ʧrm>B>2lƊҕ6,H 4{h3{I qmB{h +"iY [P@Tpm6hPJ2atS=6C["6V{j/EO{hl"){hk⓻6>R^|C[=6s{hK=ř{hk;=ұtmmNGAC[b=rmX8smm=&qbڒtmmk5=%=EЖ{hk3֖{hK=ұe-{hK=Ez Ж3Ж)hY>E[윏=]WBX~E=<xelLr` ^f&rK0>~,Ob0ؽfx.y '1Oh+'0T hp   $Bridging the Care GapDr J NiznickJoel Niznick47Microsoft PowerPoint@i-"]@T\@@kCGSg  )'    """)))UUUMMMBBB999|PP3f333f3333f3ffffff3f̙3ff333f333333333f33333333f33f3ff3f3f3f3333f33̙33333f333333f3333f3ffffff3f33ff3f3f3f3fff3ffffffffff3ffff̙fff3fffff3fff333f3f3ff3ff33f̙̙3̙ff̙̙̙3f̙3f333f3333f3ffffff3f̙3f3f3f333f3333f3ffffff3f̙3f3ffffffffff!___www4'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___wwwBBBBBBBBBBBBkBkBkBkkkBkkkkkkkkkkkkkkkkkkkkkkkBkBkBkBkBBBBBBBBBBBBBBBBBBBBBkBkBkBkBkkkkkkkkkkkkkkkkkkkkkkkkkBkBkBkBkBkBBBBBBBkpkkppppkpppk⻐p⼻⺺⻻⻻p⻐ppkp⺻᝻kkpkp⁐pkppkpkpkpkp⼺p⻼pppppkp␁pppkppp␁ppp՜.+,0     On-screen ShowOttawacvcentreZ  Times New RomanSymbol HelveticaArial CMI Template Bitmap Image.Top 10 Evidence Based Advances in CV DiseaseCTop 10 Failures to Implement Evidence Based Advances in CV DiseaseEPotential Cumulative Impact of 1 Prevention Strategies9Potential Cumulative Impact of 2 Prevention TreatmentsCVD 2 Prevention Cocktail  Fonts UsedDesign TemplateEmbedded OLE Servers Slide Titles$_ 0Joel NiznickJoel Niznick  !"#$%&')*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)Pictures{OCurrent UserSummaryInformation(UPowerPoint Document((0DocumentSummaryInformation8